(Q48004931)

English

Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study.

scientific article published in January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

0 references

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

W Ripley Ballou

1

object named as

W R Ballou

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

D. Gray Heppner

5

object named as

D G Heppner

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

J Blood

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

T Chongsuphajaissidhi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

D M Gordon

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

C Luxemburger

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

F Nosten

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

J C Sadoff

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

P Singhasivanon

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 January 1995

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

110 Suppl

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S25-36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

A Plasmodium falciparum blood stage antigen highly homologous to the glycophorin binding protein GBP

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

Characterization of SPf(66)n: a chimeric molecule used as a malaria vaccine.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

SPf66, a candidate synthetic malaria vaccine: Immunogenicity versus protection

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

Induction of protective immunity against experimental infection with malaria using synthetic peptides

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

21 January 2018

Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials of Plasmodium falciparum erythrocytic stage vaccines.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000001463

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0031182000001463

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7784126%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48004931&oldid=1726616889"